The company has significantly improved the development of an innovative solution for ATTR-CM, leveraging the compound. Initial clinical results suggests potential benefits for those suffering by the debilitating https://attruby605536.blogdun.com/42846331/bridgebio-progresses-cardiac-amyloidosis-management-with-attruby